These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 24462476)
1. Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: a systematic review. Wang RC; Jiang FM; Zheng QL; Li CT; Peng XY; He CY; Luo J; Liang ZA Respir Med; 2014 Mar; 108(3):531-7. PubMed ID: 24462476 [TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of sildenafil therapy in pulmonary artery hypertension: a meta-analysis]. Kuang TG; Wang J; Zhai ZG; Guo XH; Wang C Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1021-4. PubMed ID: 17672963 [TBL] [Abstract][Full Text] [Related]
3. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation. Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849 [TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease. Zeng WJ; Lu XL; Xiong CM; Shan GL; Liu ZH; Ni XH; Gu Q; Zhao ZH; Li JJ; He JG; Clin Cardiol; 2011 Aug; 34(8):513-8. PubMed ID: 21678455 [TBL] [Abstract][Full Text] [Related]
5. Sildenafil for pulmonary hypertension in neonates. Shah PS; Ohlsson A Cochrane Database Syst Rev; 2007 Jul; (3):CD005494. PubMed ID: 17636802 [TBL] [Abstract][Full Text] [Related]
6. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial. Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB; Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500 [TBL] [Abstract][Full Text] [Related]
7. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study. Rubin LJ; Badesch DB; Fleming TR; Galiè N; Simonneau G; Ghofrani HA; Oakes M; Layton G; Serdarevic-Pehar M; McLaughlin VV; Barst RJ; Chest; 2011 Nov; 140(5):1274-1283. PubMed ID: 21546436 [TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of randomized controlled trials on treatment of pulmonary arterial hypertension. He B; Zhang F; Li X; Tang C; Lin G; Du J; Jin H Circ J; 2010 Jul; 74(7):1458-64. PubMed ID: 20519876 [TBL] [Abstract][Full Text] [Related]
9. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546 [TBL] [Abstract][Full Text] [Related]
10. Sildenafil for pulmonary hypertension in neonates. Shah PS; Ohlsson A Cochrane Database Syst Rev; 2011 Aug; (8):CD005494. PubMed ID: 21833954 [TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension. Xu XQ; Jing ZC; Zhang JH; Wu Y; Wang Y; Jiang X; Wang ZX; Sun YG; Pu JL; Yang YJ Hypertens Res; 2009 Oct; 32(10):911-5. PubMed ID: 19644505 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension. Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071 [TBL] [Abstract][Full Text] [Related]
13. Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis. Xiao Y; Wang J; Luo H Cochrane Database Syst Rev; 2012 Apr; (4):CD009427. PubMed ID: 22513975 [TBL] [Abstract][Full Text] [Related]
14. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. McLaughlin VV; Benza RL; Rubin LJ; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubenfire M; Seeger W J Am Coll Cardiol; 2010 May; 55(18):1915-22. PubMed ID: 20430262 [TBL] [Abstract][Full Text] [Related]
15. Sildenafil for pulmonary hypertension: need for evidence generation. Shafiq N; Reddy S; Pandhi P; Manoj R; Talwar KK; Malhotra S Int J Clin Pharmacol Ther; 2008 Dec; 46(12):644-51. PubMed ID: 19049698 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of high dose generic sildenafil in Thai patients with pulmonary arterial hypertension. Durongpisitkul K; Pornrattanarungsi S; Panjasamanvong P; Chungsomprasong P J Med Assoc Thai; 2011 Apr; 94(4):421-6. PubMed ID: 21591526 [TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogs. Brown AJ; Davison E; Sleeper MM J Vet Intern Med; 2010; 24(4):850-4. PubMed ID: 20412435 [TBL] [Abstract][Full Text] [Related]
18. Effect of sildenafil on ventilatory efficiency and exercise tolerance in pulmonary hypertension. Oudiz RJ; Roveran G; Hansen JE; Sun XG; Wasserman K Eur J Heart Fail; 2007 Sep; 9(9):917-21. PubMed ID: 17707133 [TBL] [Abstract][Full Text] [Related]
19. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial. Tapson VF; Torres F; Kermeen F; Keogh AM; Allen RP; Frantz RP; Badesch DB; Frost AE; Shapiro SM; Laliberte K; Sigman J; Arneson C; Galiè N Chest; 2012 Dec; 142(6):1383-1390. PubMed ID: 22628490 [TBL] [Abstract][Full Text] [Related]